{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:59:52Z","timestamp":1792112392873,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,21]],"date-time":"2008-12-21T00:00:00Z","timestamp":1229817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1038\/nbt.1515","type":"journal-article","created":{"date-parts":[[2008,12,21]],"date-time":"2008-12-21T14:22:56Z","timestamp":1229869376000},"page":"59-65","source":"Crossref","is-referenced-by-count":1353,"title":["Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes"],"prefix":"10.1038","volume":"27","author":[{"given":"Kevin D","family":"Foust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Nurre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystal L","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis M","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K","family":"Kaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,21]]},"reference":[{"key":"BFnbt1515_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrd725","volume":"1","author":"WM Pardridge","year":"2002","unstructured":"Pardridge, W.M. Drug and gene targeting to the brain with molecular Trojan horses. Nat. Rev. Drug Discov. 1, 131\u2013139 (2002).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnbt1515_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.1086137","volume":"301","author":"BK Kaspar","year":"2003","unstructured":"Kaspar, B.K., Llado, J., Sherkat, N., Rothstein, J.D. & Gage, F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301, 839\u2013842 (2003).","journal-title":"Science"},{"key":"BFnbt1515_CR3","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1172\/JCI22922","volume":"114","author":"M Azzouz","year":"2004","unstructured":"Azzouz, M. et al. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J. Clin. Invest. 114, 1726\u20131731 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnbt1515_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature02544","volume":"429","author":"M Azzouz","year":"2004","unstructured":"Azzouz, M. et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429, 413\u2013417 (2004).","journal-title":"Nature"},{"key":"BFnbt1515_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm1205","volume":"11","author":"GS Ralph","year":"2005","unstructured":"Ralph, G.S. et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat. Med. 11, 429\u2013433 (2005).","journal-title":"Nat. Med."},{"key":"BFnbt1515_CR6","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","volume":"369","author":"MG Kaplitt","year":"2007","unstructured":"Kaplitt, M.G. et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369, 2097\u20132105 (2007).","journal-title":"Lancet"},{"key":"BFnbt1515_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","volume":"7","author":"WJ Marks Jr.","year":"2008","unstructured":"Marks, W.J. Jr. et al. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol. 7, 400\u2013408 (2008).","journal-title":"Lancet Neurol."},{"key":"BFnbt1515_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/hum.2008.022","volume":"19","author":"S Worgall","year":"2008","unstructured":"Worgall, S. et al. Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum. Gene Ther. 19, 463\u2013474 (2008).","journal-title":"Hum. Gene Ther."},{"key":"BFnbt1515_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ymthe.2004.07.016","volume":"10","author":"MJ Blankinship","year":"2004","unstructured":"Blankinship, M.J. et al. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol. Ther. 10, 671\u2013678 (2004).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nbt1073","volume":"23","author":"Z Wang","year":"2005","unstructured":"Wang, Z. et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23, 321\u2013328 (2005).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt1515_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","volume":"14","author":"K Inagaki","year":"2006","unstructured":"Inagaki, K. et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther. 14, 45\u201353 (2006).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1128\/JVI.79.1.214-224.2005","volume":"79","author":"H Nakai","year":"2005","unstructured":"Nakai, H. et al. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J. Virol. 79, 214\u2013224 (2005).","journal-title":"J. Virol."},{"key":"BFnbt1515_CR13","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1161\/01.RES.0000237661.18885.f6","volume":"99","author":"CA Pacak","year":"2006","unstructured":"Pacak, C.A. et al. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 99, e3\u2013e9 (2006).","journal-title":"Circ. Res."},{"key":"BFnbt1515_CR14","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/mt.2008.73","volume":"16","author":"C Towne","year":"2008","unstructured":"Towne, C., Raoul, C., Schneider, B.L. & Aebischer, P. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol. Ther. 16, 1018\u20131025 (2008).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/hum.2007.093","volume":"19","author":"KD Foust","year":"2008","unstructured":"Foust, K.D., Poirier, A., Pacak, C.A., Mandel, R.J. & Flotte, T.R. Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons. Hum. Gene Ther. 19, 61\u201370 (2008).","journal-title":"Hum. Gene Ther."},{"key":"BFnbt1515_CR16","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","volume":"78","author":"G Gao","year":"2004","unstructured":"Gao, G. et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381\u20136388 (2004).","journal-title":"J. Virol."},{"key":"BFnbt1515_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ymthe.2005.11.015","volume":"13","author":"CN Cearley","year":"2006","unstructured":"Cearley, C.N. & Wolfe, J.H. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol. Ther. 13, 528\u2013537 (2006).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR18","doi-asserted-by":"publisher","first-page":"9831","DOI":"10.1128\/JVI.00878-06","volume":"80","author":"B Akache","year":"2006","unstructured":"Akache, B. et al. The 37\/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J. Virol. 80, 9831\u20139836 (2006).","journal-title":"J. Virol."},{"key":"BFnbt1515_CR19","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","volume":"10","author":"DM McCarty","year":"2003","unstructured":"McCarty, D.M. et al. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther. 10, 2112\u20132118 (2003).","journal-title":"Gene Ther."},{"key":"BFnbt1515_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/sj.mt.6300331","volume":"16","author":"RL Klein","year":"2008","unstructured":"Klein, R.L., Dayton, R.D., Tatom, J.B., Henderson, K.M. & Henning, P.P. AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Mol. Ther. 16, 89\u201396 (2008).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR21","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/mt.2008.166","volume":"16","author":"CN Cearley","year":"2008","unstructured":"Cearley, C.N. et al. Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Mol. Ther. 16, 1710\u20131718 (2008).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/mthe.2001.0520","volume":"5","author":"BK Kaspar","year":"2002","unstructured":"Kaspar, B.K. et al. Targeted retrograde gene delivery for neuronal protection. Mol. Ther. 5, 50\u201356 (2002).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR23","doi-asserted-by":"publisher","first-page":"19546","DOI":"10.1073\/pnas.0609411103","volume":"103","author":"TM Miller","year":"2006","unstructured":"Miller, T.M. et al. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 103, 19546\u201319551 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1515_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/sj.mt.6300367","volume":"16","author":"ER, Hollis II","year":"2008","unstructured":"Hollis, E.R., II, Kadoya, K., Hirsch, M., Samulski, R.J. & Tuszynski, M.H. Efficient retrograde neuronal transduction utilizing self-complementary AAV1. Mol. Ther. 16, 296\u2013301 (2008).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott, N.J., Ronnback, L. & Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41\u201353 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnbt1515_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10571-004-1374-y","volume":"25","author":"NJ Abbott","year":"2005","unstructured":"Abbott, N.J. Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell. Mol. Neurobiol. 25, 5\u201323 (2005).","journal-title":"Cell. Mol. Neurobiol."},{"key":"BFnbt1515_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymthe.2006.01.012","volume":"14","author":"T Baughan","year":"2006","unstructured":"Baughan, T. et al. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector. Mol. Ther. 14, 54\u201362 (2006).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR28","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1371\/journal.pbio.0020419","volume":"2","author":"RM Siegel","year":"2004","unstructured":"Siegel, R.M. & Callaway, E.M. Francis Crick's legacy for neuroscience: between the alpha and the Omega. PLoS Biol. 2, e419 (2004).","journal-title":"PLoS Biol."},{"key":"BFnbt1515_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nn2047","volume":"11","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka, K. et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251\u2013253 (2008).","journal-title":"Nat. Neurosci."},{"key":"BFnbt1515_CR30","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/mt.2008.60","volume":"16","author":"JC Dodge","year":"2008","unstructured":"Dodge, J.C. et al. Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Mol. Ther. 16, 1056\u20131064 (2008).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR31","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper, S.Q. et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA 102, 5820\u20135825 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1515_CR32","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","volume":"12","author":"E Rodriguez-Lebron","year":"2005","unstructured":"Rodriguez-Lebron, E., Denovan-Wright, E.M., Nash, K., Lewin, A.S. & Mandel, R.J. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice. Mol. Ther. 12, 618\u2013633 (2005).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nbt1182","volume":"24","author":"N Maheshri","year":"2006","unstructured":"Maheshri, N., Koerber, J.T., Kaspar, B.K. & Schaffer, D.V. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol. 24, 198\u2013204 (2006).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt1515_CR34","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/mt.2008.100","volume":"16","author":"W Li","year":"2008","unstructured":"Li, W. et al. Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles. Mol. Ther. 16, 1252\u20131260 (2008).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR35","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/mt.2008.167","volume":"16","author":"JT Koerber","year":"2008","unstructured":"Koerber, J.T., Jang, J.H. & Schaffer, D.V. DNA shuffling of adeno-associated virus yields functionally diverse viral progeny. Mol. Ther. 16, 1703\u20131709 (2008).","journal-title":"Mol. Ther."},{"key":"BFnbt1515_CR36","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1073\/pnas.0709144105","volume":"105","author":"AM Haidet","year":"2008","unstructured":"Haidet, A.M. et al. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc. Natl. Acad. Sci. USA 105, 4318\u20134322 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt1515_CR37","doi-asserted-by":"publisher","first-page":"10409","DOI":"10.1073\/pnas.94.19.10409","volume":"94","author":"G Kempermann","year":"1997","unstructured":"Kempermann, G., Kuhn, H.G. & Gage, F.H. Genetic influence on neurogenesis in the dentate gyrus of adult mice. Proc. Natl. Acad. Sci. USA 94, 10409\u201310414 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt.1515","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.1515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.1515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:15:31Z","timestamp":1684419331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt.1515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,21]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BFnbt1515"],"URL":"https:\/\/doi.org\/10.1038\/nbt.1515","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,21]]}}}